Can Sleep Apnea Kill You? Risks, Life Expectancy & Treatments

If you’ve ever woken up gasping for air or been told you stop breathing in your sleep, that unsettling moment might linger long after the morning coffee. It’s a surprisingly common experience — roughly 12 million US adults deal with untreated obstructive sleep apnea (OSA), according to the National Heart, Lung, and Blood Institute — and it raises a question worth taking seriously: can sleep apnea kill you? The short answer involves a distinction between direct risk and the serious complications that build up over time. Here’s what medical research and major institutions actually show.

Associated health risks: Type 2 diabetes, strokes, heart attacks · Direct death risk from single episode: Rare · Untreated impact on lifespan: Shortened · Death during sleep possible: Uncommon but real · Manageable with treatment: Yes

These key facts about sleep apnea risks and outcomes come from multiple medical institutions tracking patient outcomes.

How long can you live with untreated sleep apnea?

Untreated obstructive sleep apnea doesn’t typically cause sudden death from a single episode — that’s rare. What it does is steadily erode cardiovascular health over time, creating conditions where the heart, brain, and metabolism struggle under repeated oxygen drops and sleep disruption. Several studies have shown an association between sleep apnea and problems like type 2 diabetes, strokes, heart attacks, and even a shortened lifespan (Johns Hopkins Medicine). The risks compound silently, which is why many people don’t realize how much damage has accumulated until something serious happens.

How fast can sleep apnea kill you?

When researchers followed 10,701 sleep study participants over an average of 5.3 years, they documented 142 sudden cardiac deaths — and the pattern was striking (Mayo Clinic News Network). OSA patients faced a risk nearly twofold higher than people without the condition, especially those experiencing 20 or more apnea episodes per hour with oxygen saturation dropping below 78%. One of the most notable findings: in people without OSA, sudden cardiac death peaks between 6am and noon. With OSA, that peak shifts to midnight through 6am — a window where breathing disruptions are most dangerous.

Researchers have also found that untreated OSA patients are four times more likely to develop atrial fibrillation, twice as likely to have a heart attack, and 50% more likely to have hypertension compared to those without the condition (Pulmonology Advisor). Severe OSA increases risks of coronary artery disease, heart failure, stroke, and dangerous arrhythmias (Mayo Clinic). The condition strains the cardiovascular system repeatedly through blood pressure spikes that occur every time breathing stops.

Can central sleep apnea kill you?

Central sleep apnea (CSA) differs from OSA in that the brain fails to send proper signals to breathing muscles, rather than an airway blockage. While less common than OSA, CSA carries its own serious risks because it often indicates underlying heart or neurological problems. CSA can occur alongside heart failure or after stroke, meaning the mortality risk often reflects the primary condition rather than CSA alone. Patients with CSA should seek specialized evaluation since treatment approaches differ from standard OSA management.

What causes sleep apnea?

Obstructive sleep apnea occurs when throat muscles relax during sleep, causing soft tissue to block the airway repeatedly throughout the night. When oxygen levels drop, the brain briefly wakes the body to restart breathing — often with a gasp or snort that the sleeper may not consciously remember. This cycle can repeat dozens or hundreds of times per night, fragmenting sleep without the person realizing it. The Mayo Clinic notes that obesity is one of the strongest risk factors, as excess fat tissue around the upper airway contributes to collapse during sleep.

What is the root cause of sleep apnea?

The fundamental issue is airway collapse during sleep when muscles relax. In otherwise healthy individuals, the throat structures stay open because muscle tone is sufficient. When someone has anatomical factors — a large tongue, enlarged tonsils, a recessed chin, or excess soft tissue from weight gain — the airway becomes prone to obstruction. Beyond anatomy, certain substances worsen OSA: alcohol relaxes throat muscles, sedatives can suppress arousal responses, and opioid medications affect breathing control. Age also plays a role, with risk increasing after 50 as muscle tone naturally decreases.

What common habit is linked to sleep apnea?

Excessive alcohol consumption stands out as a modifiable habit strongly linked to OSA. Alcohol relaxes the muscles that keep the upper airway open, increasing the likelihood and severity of obstructions throughout the night. Drinking within three hours of bedtime can transform mild OSA into a much more severe form. Smoking contributes indirectly by causing airway inflammation and fluid retention. Poor sleep hygiene and sleeping on one’s back also worsen symptoms, though these don’t cause OSA itself.

What are 5 symptoms of sleep apnea?

The most recognizable symptom is loud, chronic snoring, though not everyone who snores has OSA. Gasping for air during sleep — often witnessed by a bed partner — is a stronger indicator. Morning headaches result from carbon dioxide buildup and oxygen deprivation overnight. Excessive daytime fatigue despite seemingly adequate sleep hours points to fragmented sleep architecture. Difficulty concentrating stems from chronic sleep disruption that prevents proper rest cycles.

What are signs you stop breathing while sleeping?

Observable signs include gasping, choking sounds, or prolonged pauses in breathing lasting 10 seconds or longer. A bed partner may notice these episodes. Morning grogginess that doesn’t improve with more sleep, waking up with a dry mouth or sore throat, and needing to urinate frequently at night all suggest OSA. Mood changes — irritability, anxiety, or depression — often accompany untreated sleep apnea. If you notice these patterns, a sleep study can confirm whether breathing disruptions are occurring and how frequently.

What is the best treatment for sleep apnea?

CPAP (Continuous Positive Airway Pressure) remains the gold standard for moderate to severe OSA. The machine delivers pressurized air through a mask, keeping the airway open throughout sleep. A global meta-analysis examining 30 studies and 1,175,615 patients found that CPAP users experienced a 37% reduction in all-cause mortality risk compared to non-users (Pulmonology Advisor). Cardiovascular mortality specifically dropped by 55% among CPAP users — a striking finding given that heart complications represent the primary pathway from OSA to premature death.

What is sleep apnea treatment?

Beyond CPAP, treatment options include oral appliances that reposition the jaw during sleep, upper airway surgery for anatomical obstructions, and positional therapy for those whose OSA worsens while sleeping on their back. Weight loss through lifestyle modification or bariatric surgery addresses the underlying cause rather than managing symptoms. In a study of 296 OSA patients treated with nasal CPAP over 11 years and 6 months, mortality rates dropped to 7% at five years, effectively normalizing risk to near general population levels for compliant users (PubMed). Regular CPAP use shows a clear dose-response relationship — more consistent use correlates with better survival outcomes.

The key is treatment adherence. Studies consistently show that patients who use CPAP four or more hours per night derive the most benefit. For those who cannot tolerate CPAP, alternatives like adaptive servo-ventilation or hypoglossal nerve stimulation (a device that stimulates tongue movement to keep the airway open) offer emerging options. Weight control remains crucial — Johns Hopkins researchers emphasize that losing weight can either completely cure sleep apnea or substantially reduce its severity.

What is the newest treatment for sleep apnea?

The FDA approved Zepbound (tirzepatide) for treating obstructive sleep apnea in adults with obesity, representing the first pharmacological option specifically targeting OSA rather than just managing symptoms. The drug, originally developed for diabetes, works by mimicking gut hormones that regulate appetite and blood sugar, leading to significant weight loss that can reduce or eliminate OSA severity in many patients. Clinical trials showed that participants taking Zepbound experienced meaningful reductions in apnea-hypopnea index (AHI) scores, the measure used to classify OSA severity.

What is the drug for sleep apnea?

Beyond Zepbound, other weight-loss medications have shown promise for OSA treatment. Randomized controlled trials demonstrated that substantial weight reduction through GLP-1 receptor agonists or bariatric surgery can eliminate OSA in some patients. These medications work by reducing the excess soft tissue around the upper airway that contributes to obstruction. Patients interested in pharmacological options should discuss candidacy with their physician, as these treatments work best for OSA patients with obesity as a primary contributing factor.

Does Sudafed help with sleep apnea?

Pseudoephedrine (Sudafed) is sometimes tried for mild OSA because it reduces nasal congestion, potentially decreasing airway resistance. However, decongestants cannot address the fundamental problem of upper airway collapse and are not a reliable treatment for moderate or severe OSA. Some clinicians recommend nasal strips or nasal dilators for minor symptom relief, but these provide minimal benefit for true obstructive sleep apnea. Relying on over-the-counter decongestants while leaving OSA untreated poses significant cardiovascular risk.

What is the 4% rule for sleep apnea?

The “4% rule” relates to how sleep apnea severity is classified. An apnea-hypopnea index (AHI) of 5 or fewer events per hour falls within normal range. Mild OSA typically falls between 5-15 events per hour, moderate between 15-30, and severe exceeds 30 events per hour. Some classification systems use 4% oxygen desaturation as a threshold for scoring hypopneas — meaning each breathing disruption that drops blood oxygen by at least 4% gets counted in the AHI. This technical detail matters because it affects how severity is measured and reported on sleep studies.

Related reading: Nutrition Facts, Benefits and Risks

Many overlook sleep apnea as simple snoring, yet risks, signs and treatments highlight its potential to shorten lifespan through heart disease and strokes.

Frequently asked questions

“What we found that is new with this study is that if you have sleep apnea, your risk of sudden death increases almost twofold, particularly if you stopped breathing more than 20 times per hour of sleep and if you had severe falls in oxygen saturation during sleep.”

— Virend Somers, M.D., Ph.D., Mayo Clinic cardiologist

“This new study shows that sleep apnea does indeed increase the overall risk of sudden cardiac death independently of other important risk factors.”

— Apoor Gami, M.D., Mayo Clinic lead author

“Weight control is very important. There are many studies showing that losing weight can either completely cure you of sleep apnea or at least make it less severe.”

— Johns Hopkins Medicine specialist

The data from Mayo Clinic, Johns Hopkins, and major sleep research institutions converges on a clear pattern: untreated sleep apnea rarely kills instantly, but it systematically raises the odds of dying from heart problems, strokes, and related complications over years and decades. CPAP normalizes mortality risk to near general population levels when used consistently — one of the most powerful treatment effects in contemporary medicine. The newest pharmacological options like Zepbound add a tool for patients who struggle with device adherence, but the foundation remains addressing airway patency and body weight. For anyone diagnosed with OSA or experiencing its symptoms, the choice is straightforward: treat it effectively, or accept a shortened life marked by progressive cardiovascular damage.